Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Varga

Showing results (271-280 of 389) with videos related to

Pageof 39
Sort By:
Biochemical and Biophysical Research Communications|November 30, 1994
Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 regionI Laczkó, S Holly, Z Kónya, et al.
Orvosi Hetilap|March 24, 2000
[Total mesorectal excision with ultrasonic coagulation knife ("UltraCision") in surgery of rectal cancer]A Balogh, I Zöllei, L Varga, et al.
Cancer|October 5, 2002
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor IIRyszard Braczkowski, Andrew V Schally, Artur Plonowski, et al.
The Prostate|July 6, 2000
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathwaysA Plonowski, A V Schally, J L Varga, et al.
The Journal of Pediatrics|June 1, 1985
Late hyponatremia in premature infants: role of aldosterone and arginine vasopressinE Sulyok, L Kovács, B Lichardus, et al.
Orvosi Hetilap|January 5, 2002
[HLA genomic tissue typing in myasthenic patients with rheumatoid arthritis]E Varga, E Varga, R Jáger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude miceI Chatzistamou, A V Schally, J L Varga, et al.
Endocrinology|June 1, 2000
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancersZ Rekasi, J L Varga, A V Schally, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude miceAnton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.
Monographs in Neural Sciences|January 1, 1986
Renal salt-wasting increases vasopressin excretion in preterm infantsB Lichardus, E Sulyok, L Kovács, et al.
Pageof 39

Showing results (271-280 of 389) with videos related to

Sort By:
Pageof 39
Biochemical and Biophysical Research Communications|November 30, 1994
Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 regionI Laczkó, S Holly, Z Kónya, et al.
Orvosi Hetilap|March 24, 2000
[Total mesorectal excision with ultrasonic coagulation knife ("UltraCision") in surgery of rectal cancer]A Balogh, I Zöllei, L Varga, et al.
Cancer|October 5, 2002
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor IIRyszard Braczkowski, Andrew V Schally, Artur Plonowski, et al.
The Prostate|July 6, 2000
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathwaysA Plonowski, A V Schally, J L Varga, et al.
The Journal of Pediatrics|June 1, 1985
Late hyponatremia in premature infants: role of aldosterone and arginine vasopressinE Sulyok, L Kovács, B Lichardus, et al.
Orvosi Hetilap|January 5, 2002
[HLA genomic tissue typing in myasthenic patients with rheumatoid arthritis]E Varga, E Varga, R Jáger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude miceI Chatzistamou, A V Schally, J L Varga, et al.
Endocrinology|June 1, 2000
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancersZ Rekasi, J L Varga, A V Schally, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude miceAnton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.
Monographs in Neural Sciences|January 1, 1986
Renal salt-wasting increases vasopressin excretion in preterm infantsB Lichardus, E Sulyok, L Kovács, et al.
Pageof 39